Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas

Clinical trial NCT00158691 · COMPLETED

Trial details

NCT number: NCT00158691
Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2001-03-01
Enrollment: 296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.